Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

CytoDesign Inc
Profile last edited on: 4/11/16      CAGE: 414N8      UEI:

Business Identifier: human antibody therapeutics
Year Founded
2004
First Award
2005
Latest Award
2014
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4003 Scripps Avenue
Palo Alto, CA 94306
   (650) 279-5976
   rfbalint@sbcglobal.net
   N/A
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

CytoDesign Inc is a biotechnology company that uses its proprietary technologies and proven antibody development team to develop human antibody therapeutics

Extent of SBIR involvement

User Avatar
Phase I Awards
7
Phase II Awards
2
Conversion Rate
28.57%
Phase I Dollars
$1,748,371
Phase II Dollars
$197,835
Total Awarded
$1,946,206

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2014 2 NIH $399,665
Project Title: Human Proteolytic for IGA Nephropathy
2012 2 NIH $397,669
Project Title: Engineering Therapeutic Proteases
2009 1 NIH $299,750
Project Title: Proteolytic Antibodies For Treatment Of Psoriasis
2008 1 NIH $149,522
Project Title: Homogeneous Assay Platform For Clinical Diagnostics
2008 1 NIH $300,000
Project Title: Proteolytic Antibodies For Biodefense

Key People / Management

  Robert F Balint -- President

Company News

There are no news available.